RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) |
8 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 30, 2026 |
Oct. 31, 2025 |
Oct. 31, 2024 |
|
| Gain from sale of Exotropin interests | $ 390,000 | ||
| Proceeds from sale of interests in Exotropin | 376,000 | ||
| Reduction of previously recorded liabilities | 14,000 | ||
| Advances payable | $ 221,000 | ||
| Compensation expense related | 227,000 | $ 0 | 0 |
| Stock-based compensation | 4,930,000 | 4,693,000 | 3,853,000 |
| Employees, officers and directors [Member] | |||
| Compensation expense related | 799,000 | 0 | 375,000 |
| Stock-based compensation | 3,456,000 | 1,289,000 | 776,000 |
| Related Parties [Member] | |||
| Stock-based compensation | 215,000 | 2,802,000 | 2,294,000 |
| Sales representative agreement [Member] | |||
| Commissions | 0 | 45,000 | 81,000 |
| Management Services Organization [Member] | |||
| Proceed from sale of products | 0 | $ 88,000 | $ 199,000 |
| Management Services Organization [Member] | Dr. George Shapiro [Member] | |||
| Proceed from sale of products | $ 70,000 | ||